STIMULATION OF ER+ BREAST-CANCER CELLS PRIOR TO ADMINISTRATION OF CELL-CYCLE-SPECIFIC CHEMOTHERAPY

被引：0
|
作者：
KIMLER, BF
FABIAN, C
PARK, CH
机构：
[1] UNIV KANSAS,MED CTR,DEPT RADIAT THERAPY,KANSAS CITY,KS 66103
[2] UNIV KANSAS,MED CTR,DEPT MED,KANSAS CITY,KS 66103
来源：
CELL AND TISSUE KINETICS | 1983年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [21] E2F cell cycle pathway score as a predictive biomarker of ER+/HER2-breast cancer response to neoadjuvant chemotherapy.
    Oshi, Masanori
    Tokumaru, Yoshihisa
    Katsuta, Eriko
    Yan, Li
    Endo, Itaru
    Takabe, Kazuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] VITAMIN-A STIMULATION OF SPECIFIC CELL-MEDIATED-IMMUNITY IN BREAST-CANCER PATIENTS
    BLACK, MM
    ZACHRAU, RE
    DION, AS
    KATZ, M
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1197 - 1197
  • [23] CELL-CYCLE-SPECIFIC CDNAS FROM MAMMALIAN-CELLS TEMPERATURE SENSITIVE FOR GROWTH
    HIRSCHHORN, RR
    ALLER, P
    YUAN, ZA
    GIBSON, CW
    BASERGA, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (19): : 6004 - 6008
  • [24] AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells
    Hampsch, Riley A.
    Wells, Jason D.
    Traphagen, Nicole A.
    McCleery, Charlotte F.
    Fields, Jennifer L.
    Shee, Kevin
    Dillon, Lloye M.
    Pooler, Darcy B.
    Lewis, Lionel D.
    Demidenko, Eugene
    Huang, Yina H.
    Marotti, Jonathan D.
    Goen, Abigail E.
    Kinlaw, William B.
    Miller, Todd W.
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3707 - 3719
  • [25] Methioninase S-phase block of cancer cells imaged in real time by cell-cycle-specific fluorescence reporters
    Yano, Shuya
    Li, Shukuan
    Han, Qinghong
    Tan, Yuying
    Fujiwara, Toshiyoshi
    Hoffman, Robert M.
    CANCER RESEARCH, 2012, 72
  • [26] MYB is involved in the DNA damage response in human ER+ breast cancer cells
    Yang, R-M
    Dray, E.
    Mitra, P.
    Gonda, T. J.
    CANCER RESEARCH, 2016, 76
  • [27] EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer
    Katsyv, Igor
    Wang, Minghui
    Song, Won Min
    Zhou, Xianxiao
    Zhao, Yongzhong
    Park, Sun
    Zhu, Jun
    Zhang, Bin
    Irie, Hanna Y.
    ONCOTARGET, 2016, 7 (43) : 69592 - 69605
  • [28] HORMONAL SYNCHRONIZATION BEFORE CYCLE SPECIFIC CHEMOTHERAPY IN ADVANCED BREAST-CANCER - OUR EXPERIENCE WITH ALLEGRA REGIMEN
    ZANIBONI, A
    SIMONCINI, E
    MARPICATI, P
    GORNI, F
    CERUTTI, L
    MARINI, G
    ANTICANCER RESEARCH, 1986, 6 (03) : 393 - 394
  • [29] SITE-SPECIFIC EFFECT OF CHEMOTHERAPY IN PATIENTS WITH BREAST-CANCER
    KAMBY, C
    VESTLEV, PM
    MOURIDSEN, HT
    ACTA ONCOLOGICA, 1992, 31 (02) : 225 - 229
  • [30] CELL CYCLE-SPECIFIC GROWTH-INHIBITION OF HUMAN BREAST-CANCER CELLS INDUCED BY METABOLIC-INHIBITORS
    LARSSON, O
    GLYCOBIOLOGY, 1993, 3 (05) : 475 - 479
12345